Domchek, Susan M ;
Postel-Vinay, Sophie ;
Im, Seock-Ah...
Domchek , S M , Postel-Vinay , S , Im , S-A , Park , Y H , Delord , J-P , Italiano , A , Alexandre , J , You , B , Bastian , S , Krebs , M G , Wang , D , Waqar , S N , Lanasa , M , Rhee , J , Gao , H , Rocher-Ros , V , Jones , E V , Gulati , S , Coenen-Stass , A , Kozarewa , I , Lai , Z , Angell , H K , Opincar , L , Herbolsheimer , P & Kaufman , B 2020 , ' Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA) : an open-label, multicentre, phase 1/2, basket study ' , The Lancet. Oncology , vol. 21 , no. 9 , pp. 1155-1164 . https://doi.org/10.1016/S1470-2045(20)30324-7.
,
2020
